A proteolytic enzyme is the key therapeutic target in biomedical research of LPR» Our Mission
LPR symptoms reduce ones quality of life and contribute to life-threatening illnesses.» What is LPR?
How N-Zyme is addressing significant unmet clinical needs in LPR treatment.» Learn more
We aim to create the world's first pepsin inhibitor as a revolutionary form of treatment for LPR.Request Corporate Presentation
Enter your email to get the latest developments on N-Zyme, including our research, clinical trials and corporate reports.